GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Makers Laboratories Ltd (BOM:506919) » Definitions » Construction In Progress

Makers Laboratories (BOM:506919) Construction In Progress : ₹3 Mil (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Makers Laboratories Construction In Progress?

Makers Laboratories's quarterly construction in progress declined from Sep. 2023 (₹18 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹3 Mil).

Makers Laboratories's annual construction in progress declined from Mar. 2022 (₹94 Mil) to Mar. 2023 (₹5 Mil) and declined from Mar. 2023 (₹5 Mil) to Mar. 2024 (₹3 Mil).


Makers Laboratories Construction In Progress Historical Data

The historical data trend for Makers Laboratories's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Makers Laboratories Construction In Progress Chart

Makers Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.57 1.70 93.84 4.54 3.16

Makers Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.54 - 18.12 - 3.16

Makers Laboratories Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Makers Laboratories (BOM:506919) Business Description

Traded in Other Exchanges
N/A
Address
54-D, Kandivli Industrial Estate, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti cough Range), and Exylin (Amoxycillin range) among others.

Makers Laboratories (BOM:506919) Headlines

No Headlines